1[1]World Health Organization.Assessment of fracture risksand its application to screening for postmenopausal osteoporosis.WHO Technical Report Series 843.Geneva:WHO.1994.
2[2]Slemenda CW,Christian JC,Williams CJ,et al.Genetic determinants of bone mass in adult women:a reevaluation of the twin model and thepotential importance of gene interaction on heritability estimates.J Bone Miner Res,1991,6:561-567.
3[3]Taaffe DR,Robinson TL,Snow CM,et al.Highimpactexercise promotes bone gain in well-trained female athletes.J Bone Miner Res,1997,12:255-260.
4[4]Rapuri PB,Gallagher JC,Balhorn KE,et al.Alcohol intake and bone metabolism in elderly women.Am J Clin Nutr,2000,72:1206-1213.
5[5]ACOG Practice Bulletin No.50.Osteoporosis.Clinical management guidelines for ogstetrician-gynecologists.Obstetrics and Gynecsology,2004,103:203-216.
6[6]Kanis JA,Johnell O,Oden A,et al.Risk of hip fracture derived from relative risks:an analysis applied to the population of Sweden.Osteoporos Int,2000,11:120-127.
7[7]Rossouw JE,Anderson GL,Prentice RL,et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the Women' s Health Initiative randomized controlled trial.JAMA,2002,288:321-333.
8[8]Lindsay R,Gallagher JC,Kleerekoper M,et al.Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early post-menopausal women.JAMA,2002,287:2668-2676.
10[10]Gallagher JC,Baylink DJ,Freeman R,et al.Prevention of bone loss with tibolone in postmenopausal women:results of two randomized,double-blind,placebo-controlled,dose-finding studies.J Clin Endocrinol Metab,2001,86:4717-4726.
二级参考文献5
1Christiansen C.Hormone replacement therapy and osteoporosis[].Maturitas.1996
2Christensen MS,Hagen C,Christiansen C,et al.Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women:placebo-controlled trial of its gynecologic and metabolic actions[].American Journal of Obstetrics and Gynecology.1982
3Mizunuma H,Okano H,Soda M,et al.Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen/progestin therapy: a 2-year prospective study[].Maturitas.1997
4Felson DT,Zhang Y,Hannan MT,et al.The effect of postmenopausal estrogen therapy on bone densityn in elderly women[].The New England Journal of Medicine.1993
5Prestwood KM,Pilbeam CC,Burleson JA,et al.The short-term effects of conjugated esteogen on bone turnover in older women[].The Journal of Clinical Endocrinology.1994
